Literature DB >> 28609431

Polymorphisms in urea cycle enzyme genes are associated with persistent pulmonary hypertension of the newborn.

Dinushan C Kaluarachchi1, Caitlin J Smith2, Jonathan M Klein1, Jeffrey C Murray1, John M Dagle1, Kelli K Ryckman2.   

Abstract

BackgroundPersistent pulmonary hypertension of the newborn (PPHN) is characterized by elevated pulmonary vascular resistance. Endogenous nitric oxide is critical for regulation of pulmonary vascular resistance. Nitric oxide is generated from L-arginine, supplied by the urea cycle (UC). We hypothesized that polymorphisms in UC enzyme genes and low concentrations of UC intermediates are associated with PPHN.MethodsWe performed a family-based candidate gene analysis to study 48 single-nucleotide polymorphisms (SNPs) in six UC enzyme genes. Genotyping was carried out in 94 infants with PPHN and their parents. We also performed a case-control analysis of 32 cases with PPHN and 64 controls to identify an association between amino-acid levels on initial newborn screening and PPHN.ResultsThree SNPs (rs41272673, rs4399666, and rs2287599) in carbamoyl phosphate synthase 1 gene (CPS1) showed a significant association with PPHN (P=0.02). Tyrosine levels were significantly lower (P=0.003) and phenylalanine levels were significantly higher (P=0.01) in cases with PPHN. There was no difference in the arginine or citrulline levels between the two groups.ConclusionsThis study suggests an association (P<0.05) between SNPs in CPS1 and PPHN. These findings warrant further replication in larger cohorts of patients.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28609431      PMCID: PMC5811332          DOI: 10.1038/pr.2017.143

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  29 in total

1.  Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure.

Authors: 
Journal:  N Engl J Med       Date:  1997-02-27       Impact factor: 91.245

2.  Neonatal pulmonary hypertension--urea-cycle intermediates, nitric oxide production, and carbamoyl-phosphate synthetase function.

Authors:  D L Pearson; S Dawling; W F Walsh; J L Haines; B W Christman; A Bazyk; N Scott; M L Summar
Journal:  N Engl J Med       Date:  2001-06-14       Impact factor: 91.245

3.  The hemochromatosis C282Y allele: a risk factor for hepatic veno-occlusive disease after hematopoietic stem cell transplantation.

Authors:  A R Kallianpur; L D Hall; M Yadav; D W Byrne; T Speroff; R S Dittus; J L Haines; B W Christman; M L Summar
Journal:  Bone Marrow Transplant       Date:  2005-06       Impact factor: 5.483

4.  Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn. Clinical Inhaled Nitric Oxide Research Group.

Authors:  R H Clark; T J Kueser; M W Walker; W M Southgate; J L Huckaby; J A Perez; B J Roy; M Keszler; J P Kinsella
Journal:  N Engl J Med       Date:  2000-02-17       Impact factor: 91.245

5.  Variations in CRHR1 are associated with persistent pulmonary hypertension of the newborn.

Authors:  Heather M Byers; John M Dagle; Jonathan M Klein; Kelli K Ryckman; Erin L McDonald; Jeffrey C Murray; Kristi S Borowski
Journal:  Pediatr Res       Date:  2011-12-21       Impact factor: 3.756

6.  Association of ornithine transcarbamylase gene polymorphisms with hypertension and coronary artery vasomotion.

Authors:  Julie Dumont; Djabaria Meroufel; Christophe Bauters; Franck Hansmannel; Faïza Bensemain; Dominique Cottel; Martial Hamon; Jean-Charles Lambert; Pierre Ducimetière; Philippe Amouyel; Mahmoud Zureik; Thierry Brousseau
Journal:  Am J Hypertens       Date:  2009-07-02       Impact factor: 2.689

7.  ARG1 is a novel bronchodilator response gene: screening and replication in four asthma cohorts.

Authors:  Augusto A Litonjua; Jessica Lasky-Su; Kady Schneiter; Kelan G Tantisira; Ross Lazarus; Barbara Klanderman; John J Lima; Charles G Irvin; Stephen P Peters; John P Hanrahan; Stephen B Liggett; Gregory A Hawkins; Deborah A Meyers; Eugene R Bleecker; Christoph Lange; Scott T Weiss
Journal:  Am J Respir Crit Care Med       Date:  2008-07-10       Impact factor: 21.405

8.  Association of arginase 1 gene polymorphisms with the risk of myocardial infarction and common carotid intima media thickness.

Authors:  Julie Dumont; Mahmoud Zureik; Dominique Cottel; Michèle Montaye; Pierre Ducimetière; Philippe Amouyel; Thierry Brousseau
Journal:  J Med Genet       Date:  2007-03-16       Impact factor: 6.318

9.  Arginase I gene single-nucleotide polymorphism is associated with decreased risk of pulmonary hypertension in bronchopulmonary dysplasia.

Authors:  J K Trittmann; L D Nelin; E J Zmuda; J M Gastier-Foster; B Chen; C H Backes; J Frick; P Vaynshtok; V J Vieland; M A Klebanoff
Journal:  Acta Paediatr       Date:  2014-07-06       Impact factor: 2.299

10.  Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase.

Authors:  H Ischiropoulos; L Zhu; J Chen; M Tsai; J C Martin; C D Smith; J S Beckman
Journal:  Arch Biochem Biophys       Date:  1992-11-01       Impact factor: 4.013

View more
  13 in total

Review 1.  Inborn errors of metabolism in the 21st century: past to present.

Authors:  Georgianne L Arnold
Journal:  Ann Transl Med       Date:  2018-12

Review 2.  CPS1: Looking at an ancient enzyme in a modern light.

Authors:  Matthew Nitzahn; Gerald S Lipshutz
Journal:  Mol Genet Metab       Date:  2020-10-10       Impact factor: 4.797

3.  Association between genetic variations in carbamoyl-phosphate synthetase gene and persistent neonatal pulmonary hypertension.

Authors:  Nashwa El-Khazragy; Mohamed El Barbary; Hala Fouad; Abdallah Abdelgawad; Dina Rabie
Journal:  Eur J Pediatr       Date:  2021-03-27       Impact factor: 3.183

4.  Metabolic differences among newborns born to mothers with a history of leukemia or lymphoma.

Authors:  Sonia T Anand; Kelli K Ryckman; Rebecca J Baer; Mary E Charlton; Patrick J Breheny; William W Terry; Kord Kober; Scott Oltman; Elizabeth E Rogers; Laura L Jelliffe-Pawlowski; Elizabeth A Chrischilles
Journal:  J Matern Fetal Neonatal Med       Date:  2021-05-12

5.  Tandem Mass Tag-Based Proteomic Analysis of Potential Biomarkers for Hepatocellular Carcinoma Differentiation.

Authors:  Wei Wang; Qiang Li; Ge Huang; Bing-Yao Lin; Dongzi Lin; Yan Ma; Zhao Zhang; Tao Chen; Jie Zhou
Journal:  Onco Targets Ther       Date:  2021-02-12       Impact factor: 4.147

6.  Metabolic Reprogramming of the Right Ventricle and Pulmonary Arteries in a Flow-Associated Pulmonary Arterial Hypertension Rat Model.

Authors:  Dongli Liu; Suyuan Qin; Danyan Su; Kai Wang; Yanyun Huang; Yuqin Huang; Yusheng Pang
Journal:  ACS Omega       Date:  2021-12-27

7.  A constitutive knockout of murine carbamoyl phosphate synthetase 1 results in death with marked hyperglutaminemia and hyperammonemia.

Authors:  Suhail Khoja; Matthew Nitzahn; Brian Truong; Jenna Lambert; Brandon Willis; Gabriella Allegri; Véronique Rüfenacht; Johannes Häberle; Gerald S Lipshutz
Journal:  J Inherit Metab Dis       Date:  2019-03-05       Impact factor: 4.750

8.  Metabolic reprogramming of the urea cycle pathway in experimental pulmonary arterial hypertension rats induced by monocrotaline.

Authors:  Hai-Kuo Zheng; Jun-Han Zhao; Yi Yan; Tian-Yu Lian; Jue Ye; Xiao-Jian Wang; Zhe Wang; Zhi-Cheng Jing; Yang-Yang He; Ping Yang
Journal:  Respir Res       Date:  2018-05-11

9.  Characteristics of the urinary microbiome in kidney stone patients with hypertension.

Authors:  Fengping Liu; Nan Zhang; Peng Jiang; Qixiao Zhai; Chen Li; Deshui Yu; Yan Wu; Yuwei Zhang; Longxian Lv; Xinyu Xu; Ninghan Feng
Journal:  J Transl Med       Date:  2020-03-17       Impact factor: 5.531

10.  Customized Massive Parallel Sequencing Panel for Diagnosis of Pulmonary Arterial Hypertension.

Authors:  Jair Antonio Tenorio Castaño; Ignacio Hernández-Gonzalez; Natalia Gallego; Carmen Pérez-Olivares; Nuria Ochoa Parra; Pedro Arias; Elena Granda; Gonzalo Gómez Acebo; Mauro Lago-Docampo; Julian Palomino-Doza; Manuel López Meseguer; María Jesús Del Cerro; Spanish Pah Consortium; Diana Valverde; Pablo Lapunzina; Pilar Escribano-Subías
Journal:  Genes (Basel)       Date:  2020-09-30       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.